['Toxic Substances Control Act - EPA']

['Toxic Substances - EPA', 'Toxic Subtances Control Act - EPA']

12/17/2024

HOME NEWS REGSENSE INSTITUTE EDGE EXPERT HELP EVENTS FORUMS

FREE TRIAL UPGRADE!

Thank you for investing in EnvironmentalHazmatHuman ResourcesHuman Resources, Hazmat & Environmental related content. Click 'UPGRADE' to continue.

CANCEL

UPGRADE

YOU'RE ALL SET!

Enjoy your limited-time access to the Compliance Network!

A confirmation welcome email has been sent to your email address from ComplianceNetwork@t.jjkellercompliancenetwork.com. Please check your spam/junk folder if you can't find it in your inbox.

CONTINUE

YOU'RE ALL SET!

Thank you for your interest in EnvironmentalHazmatHuman ResourcesHuman Resources, Hazmat & Environmental related content.

CONTINUE

WHOOPS!

You've reached your limit of free access, if you'd like more info, please contact us at 800-327-6868.

By signing in for J. J. Keller® Compliance Network, you agree to the J. J. Keller® Terms of Use . For information about how we use any personal information we collect for our own purposes, please review our Notice at Collection .

Your Compliance Network account is no longer active, please call support at 1-833-982-1232 option 3, to reactivate your account.

There is no account associated with this email.

Your Compliance Network account will use the same sign in credentials as the following J.J. Keller sites. Please enter the same password you use to access:
Please note: Any changes to your credentials will affect all products.
Contact Support at 1-833-982-1232 or compliancenetwork@jjkeller.com

Password

To enhance your account's security, you need to confirm your email address and reset your password.

To reset your password, enter the 6-digit verification code sent to csquires@jjkeller.com.

* Field cannot be blank

If you don't see the email in your inbox, please check your spam folder.

Password

Re-enter Password

Secure password tips:

Password is case sensitive.
Use at least 12 characters.
Use at least one upper and one lower case letter.
Use at least 1 number.
Password may contain special characters: ! @ # $ % ^ & * ( ) ... - + = { }
Your password cannot be any of the last 4 passwords.
Password expires every 365 days.

You already have a Compliance Network account, please sign in.

test@email.com

Your Compliance Network account will use the same sign in credentials as the following J.J. Keller sites. Please enter the same password you use to access:
Please note: Any changes to your credentials will affect all products.
Contact Support at 1-833-982-1232 or compliancenetwork@jjkeller.com

Password

To enhance your account's security, you need to confirm your email address and reset your password.

To reset your password, enter the 6-digit verification code sent to csquires@jjkeller.com.

* Field cannot be blank

If you don't see the email in your inbox, please check your spam folder.

Password

Re-enter Password

Secure password tips:

Password is case sensitive.
Use at least 12 characters.
Use at least one upper and one lower case letter.
Use at least 1 number.
Password may contain special characters: ! @ # $ % ^ & * ( ) ... - + = { }
Your password cannot be any of the last 4 passwords.
Password expires every 365 days.

Your Compliance Network account is no longer active, please call support at 1-833-982-1232 option 3, to reactivate your account.

§721.1907 Butanamide, 2, 2' -[3' dichloro[1, 1' -biphenyl]-4, 4' - diyl)bisazobis N-2, 3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo-.

...

§721.1907 Butanamide, 2, 2' -[3' dichloro[1, 1' -biphenyl]-4, 4' - diyl)bisazobis N-2, 3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo-.

RegSense Toxic Substances Control Act - EPA Toxic Subtances Control Act - EPA Toxic Substance Control Toxic Substances - EPA CFR Regulations Environmental Protection Agency (EPA)Environmental CFR Section English Focus Area USA

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as butanamide, 2,2'-[3'dichloro[1,1'-biphenyl]-4,4'-diyl)bisazobis N-2,3- dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo- (PMN P-93-1111) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.

(2) The significant new uses are: